Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival.
about
Interventions for treating pulmonary hypertension in people with sickle cell disease or thalassaemiaMutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell diseaseMedical management of ischemic stuttering priapism: a contemporary review of the literatureThe critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis modelGroup 5 Pulmonary Hypertension: The Orphan's Orphan Disease.Echocardiographic evaluation of left ventricular diastolic and systolic function in Saudi patients with sickle cell disease.Pulmonary complications of sickle cell disease.Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell diseasePulmonary hypertension in Nigerian adults with sickle cell anemia.Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation.NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in AfricaExercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1.Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell diseaseSildenafil therapy in patients with sickle cell disease and pulmonary hypertension.Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia.Hemolysis-associated pulmonary hypertension in thalassemia.Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell diseaseVasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsSevere painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study.Vasculopathy and pulmonary hypertension in sickle cell disease.Uric Acid as a potential biomarker of pulmonary arterial hypertension in patients with sickle cell disease.Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesPrevalence of pulmonary hypertension in sickle cell anaemia patients of a tertiary hospital in NigeriaEchocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease.Pleiotropic effects of intravascular haemolysis on vascular homeostasis.Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.Managing sickle cell disease.Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersCorrelation of N-terminal fragment of B-type natriuretic peptide levels with clinical, laboratory, and echocardiographic abnormalities in children with sickle cell disease.Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailabilityCharacterization of altered patterns of endothelial progenitor cells in sickle cell disease related pulmonary arterial hypertension.Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobinSildenafil in the treatment of pulmonary hypertension.LimiTT: link miRNAs to targets.
P2860
Q24187475-846B012D-6836-4369-884A-13B6AEFA13A8Q24606163-BFA4D199-DBAB-468D-BFB7-CF72FC673ED4Q26851728-2014F256-DCBD-4BE0-A2CF-0D7F8632D389Q28512770-7F60E79F-36F8-41A8-B3A2-245EF7CA88ECQ30248872-5AA0B389-AE42-4790-88D1-53042E1F2F5EQ30447935-9A21D7C8-1B3C-43AB-A31A-63505AEA1BBBQ30515769-E3205550-37FE-4EB0-A3DF-82161D2C2C30Q33385956-83C6475A-C709-456F-92EB-BBD92D4D55A6Q33674097-AEC9606C-3132-435A-B7F8-0E65629187BBQ33790168-2967C7E7-4D80-4CCA-8225-C99D8FCA69FFQ33803027-1C82B917-C6EA-4F79-814B-AC869E804233Q33899415-104F8B9B-347F-4EA9-AD59-88A5C78A2380Q33997200-27227C57-393C-4959-BDD9-D301ACADC415Q34009129-783532CE-630F-41D7-A968-3B7EBFF9B3D8Q34038886-BCA1D68D-32D1-42A7-9A0F-A99790DF51BFQ34073285-DA848F47-56EF-4D66-B4AE-5C42B02A27B9Q34431518-609C2999-CA0D-4F5D-BFDE-C4BF791A809AQ34436782-425E392F-3E28-418E-8B0B-3A08E68685EAQ34451512-DAA1001F-3D73-4239-90A7-CB01467F8F81Q34474615-9B568BDC-225A-464C-B806-617CCD54179FQ34734804-12EF46B6-386F-4F0C-BF02-AE49BBF43C59Q34992760-27038F76-BE73-4806-8514-1DEF5E5BA832Q35041547-12ACC32E-2DCA-4C61-97C2-50B294892F1FQ35086394-AD50C2A9-5F56-45EA-897E-5CBB5DB96F14Q35106381-61A57A3F-BC81-4142-A756-B66ADEC7FCBFQ35140978-D20805C8-97C3-43C6-A290-C5FD264EC5E8Q35156618-F6D4D59C-F902-408C-A69D-E3391AC34A41Q35162157-1AC60134-0462-430D-B824-2C9D94577890Q35243386-2669368B-6688-4063-A20F-9CBBCCE3692CQ35399728-DC6E2A51-0756-45F2-A64D-468D88923D34Q35535204-6DDDD2D2-F2C6-4684-B63A-C461A585EAFDQ35576474-9A2348AD-4CA9-4823-BB67-DA31F2CEE9CCQ35582684-D563F7D4-5ADF-47FF-9F5E-8D8FE14C300DQ35590733-35995BE4-3DC6-4A2E-A9C9-1FA9E1E9AE2BQ35742699-EC3ADB06-DB17-44A8-A0BC-8C96C832C4C1Q35750972-C0C12701-A70D-4B70-B67E-3C8447630CFEQ35929761-D990A240-F583-4D8A-9948-21DF06242DA3Q35990633-E0B9C430-DFB0-4890-8634-DB26447239C0Q36013070-3213BD37-AA32-48EA-9DAD-54D22E66D753Q36015196-AD34D732-6F42-4B7A-B891-31C13C77B204
P2860
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Pulmonary hypertension in sick ...... rization results and survival.
@en
Pulmonary hypertension in sick ...... rization results and survival.
@nl
type
label
Pulmonary hypertension in sick ...... rization results and survival.
@en
Pulmonary hypertension in sick ...... rization results and survival.
@nl
prefLabel
Pulmonary hypertension in sick ...... rization results and survival.
@en
Pulmonary hypertension in sick ...... rization results and survival.
@nl
P2093
P1433
P1476
Pulmonary hypertension in sick ...... rization results and survival.
@en
P2093
Bernice D Brown
Mohammed Hoque
Oswaldo Castro
P304
P356
10.1182/BLOOD-2002-03-0948
P407
P577
2002-10-03T00:00:00Z